Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Significant progress has been made on approaches targeting GPCRs such as single peptides that simultaneously activate GIP and/or GCGR in addition to GLP1, oral tablet formulation of GLP-1, small molecules nonpeptidic oral GLP1R and fixed-dose combination as well as add-on therapy for patients already treated with a GLP-1 agonist
A 1mg/ml concentration requires a full syringe just for a 1.0mg dose, and higher doses literally do not fit in a standard 1ml syringe
The researchers noted these results provide rationale for larger clinical trials
Sublingual is more convenient and needle-free, making it preferable for patients who cannot or will not self-inject
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
